The DOI matches its Crossref record; 146 of the 150 references it cites were found in a registry or an index.
Liver X receptors in lipid signalling and membrane homeostasis
Open accessAbstract
Liver X receptors α and β (LXRα and LXRβ) are nuclear receptors with pivotal roles in the transcriptional control of lipid metabolism. Transcriptional activity of LXRs is induced in response to elevated cellular levels of cholesterol. LXRs bind to and regulate the expression of genes that encode proteins involved in cholesterol absorption, transport, efflux, excretion and conversion to bile acids. The coordinated, tissue-specific actions of the LXR pathway maintain systemic cholesterol homeostasis and regulate immune and inflammatory responses. LXRs also regulate fatty acid metabolism by controlling the lipogenic transcription factor sterol regulatory element-binding protein 1c and regulate genes that encode proteins involved in fatty acid elongation and desaturation. LXRs exert important effects on the metabolism of phospholipids, which, along with cholesterol, are major constituents of cellular membranes. LXR activation preferentially drives the incorporation of polyunsaturated fatty acids into phospholipids by inducing transcription of the remodelling enzyme lysophosphatidylcholine acyltransferase 3. The ability of the LXR pathway to couple cellular sterol levels with the saturation of fatty acids in membrane phospholipids has implications for several physiological processes, including lipoprotein production, dietary lipid absorption and intestinal stem cell proliferation. Understanding how LXRs regulate membrane composition and function might provide new therapeutic insight into diseases associated with dysregulated lipid metabolism, including atherosclerosis, diabetes mellitus and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Liver X receptor transcription factors are key regulators of cholesterol metabolism (29, 30).”
From Aster-dependent nonvesicular transport facilitates dietary cholesterol uptake (2023) · cites this paper as [29]
In the citing paper
“Following systemic adsorption, some secondary BAs in turn impact host physiology though interaction with a variety of host nuclear receptors including FXR, liver X receptor (LXR), pregnane X receptor (PXR), and specific G-protein coupled receptors like TGR5 (Figure 1)40–44.”
From Gut microbiota and cardiovascular disease. (2020) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Macrophages in atherosclerosis: a dynamic balance
Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3520 · Cited by 2,559
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Hörlein, A., Näär, A. M., Heinzel, T., Torchia, J., Gloss, B. R., Kurokawa, R., Ryan, A. K., Kamei, Y., Söderström, M., Glass, C. K., et al. (1995) · Nature · doi:10.1038/377397a0 · Cited by 2,072
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
Altmann, S. W., Davis, H. R., Zhu, L.-J., Yao, X., Hoos, L. M., Tetzloff, G. G., Iyer, S. P. N., Maguire, M., Golovko, A., Zeng, M., et al. (2004) · Science · doi:10.1126/science.1093131 · Cited by 1,818
A transcriptional co-repressor that interacts with nuclear hormone receptors
Chen, J. D., & Evans, R. M. (1995) · Nature · doi:10.1038/377454a0 · Cited by 1,794
Cited by
Sorted by citations
Gut microbiota and cardiovascular disease.
Witkowski, M., Weeks, T. L., & Hazen, S. L. (2020) · Circulation Research · doi:10.1161/circresaha.120.316242 · Cited by 1,051
Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities
Huang, B., Song, B., & Xu, C. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0174-0 · Cited by 962
Metabolic signaling in T cells
Shyer, J. A., Flavell, R. A., & Bailis, W. (2020) · Cell Research · doi:10.1038/s41422-020-0379-5 · Cited by 346
Targeted protein degradation: advances in drug discovery and clinical practice
Zhong, G., Chang, X., Xie, W., & Zhou, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02004-x · Cited by 326
Functional significance of cholesterol metabolism in cancer: from threat to treatment
Xiao, M., Xu, J., Wang, W., Zhang, B., Liu, J., Li, J., Xu, H., Zhao, Y., Yu, X., & Shi, S. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01079-w · Cited by 260
Enterically derived high-density lipoprotein restrains liver injury through the portal vein
Han, Y.-H., Onufer, E. J., Huang, L.-H., Sprung, R. W., Davidson, W. S., Czepielewski, R. S., Wohltmann, M., Sorci-Thomas, M. G., Warner, B. W., & Randolph, G. J. (2021) · Science · doi:10.1126/science.abe6729 · Cited by 210
Inhibition of ASGR1 decreases lipid levels by promoting cholesterol excretion
Wang, J.-Q., Li, L.-L., Hu, A., Deng, G., Wei, J., Li, Y.-F., Liu, Y.-B., Lu, X.-Y., Qiu, Z.-P., Shi, X.-J., et al. (2022) · Nature · doi:10.1038/s41586-022-05006-3 · Cited by 188
Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease
Chao, H., Chao, S.-W., Lin, H., Ku, H., & Cheng, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020298 · Cited by 192
Citrobacter rodentium–host–microbiota interactions: immunity, bioenergetics and metabolism
Mullineaux-Sanders, C., Sanchez‐Garrido, J., Hopkins, E. G. D., Shenoy, A. R., Barry, R. E., & Frankel, G. M. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0252-z · Cited by 180
RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype
Cai, D., Wang, J., Gao, B., Li, J., Wu, F., Zou, J. X., Xu, J., Jiang, Y., Zou, H., Huang, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12529-3 · Cited by 167
SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection
Ανδρουτσάκος, Θ., Ansari, N. N., Bakasis, A., Kyrou, I., EFSTATHOPOULOS, E. P., Randeva, H. S., & Kassi, E. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063107 · Cited by 176
The Role of the ATP-Binding Cassette A1 (ABCA1) in Human Disease
Jacobo‐Albavera, L., Domínguez‐Pérez, M., Medina-Leyte, D. J., González-Garrido, A., & Villarreal-Molina, M. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041593 · Cited by 172
Influence of cholesterol on cancer progression and therapy
Mayengbam, S. S., Singh, A., Pillai, A. D., & Bhat, M. K. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101043 · Cited by 155
Wang, H., Wang, Z., Zhang, Z., Liu, J., & Li, H. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.05.013 · Cited by 171
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics
Ma, X., Huang, T., Chen, X., Li, Q., Liao, M., Fu, L., Huang, J., Yuan, K., Wang, Z., & Zeng, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02104-8 · Cited by 133
Lipid metabolism in pancreatic cancer: emerging roles and potential targets
Yin, X., Xu, R., Song, J., Ruze, R., Chen, Y., Wang, C., & Xu, Q. (2022) · 癌症:英文版 · doi:10.1002/cac2.12360 · Cited by 134
Familial Hypercholesterolemia: The Most Frequent Cholesterol Metabolism Disorder Caused Disease
Benito‐Vicente, A., Uribe, K. B., Jebari‐Benslaiman, S., Galicia-García, U., Ostolaza, H., & Martín, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113426 · Cited by 151
Kwon, J., Lee, C., Heo, S., Kim, B., & Hyun, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-84761-1 · Cited by 127
Giacomini, I., Gianfanti, F., Desbats, M. A., Orso, G., Berretta, M., Prayer‐Galetti, T., Ragazzi, E., & Cocetta, V. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.682911 · Cited by 121
Cholesterol metabolism: a new molecular switch to control inflammation
Cardoso, D., & Perucha, E. (2021) · Clinical Science · doi:10.1042/cs20201394 · Cited by 116
LXR signaling controls homeostatic dendritic cell maturation
Bosteels, V., Maréchal, S., Nolf, C. D., Rennen, S., Maelfait, J., Tavernier, S. J., Vetters, J., Velde, E. V. D., Fayazpour, F., Deswarte, K., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.add3955 · Cited by 114
Type III secretion system effectors form robust and flexible intracellular virulence networks
Ruano‐Gallego, D., Sanchez‐Garrido, J., Kozik, Z., Berrueco, E. N., Cepeda-Molero, M., Mullineaux-Sanders, C., Baghshomali, Y. N., Slater, S. L., Wagner, N., Glegola-Madejska, I., et al. (2021) · Science · doi:10.1126/science.abc9531 · Cited by 110
Wang, K., Gao, H., Zhang, Y., Yan, H., Si, J., Mi, X., Xia, S., Feng, X., Liu, D., Kong, D., et al. (2021) · Advanced Materials · doi:10.1002/adma.202106994 · Cited by 110
Hou, Y., Wang, Z., Liu, P., Wei, X., Zhang, Z., Fan, S., Zhang, L., Han, F., Song, Y., Chu, L., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.10.001 · Cited by 112
Vinuesa, Á., Pomilio, C. J., Gregosa, A., Bentivegna, M., Presa, J., Bellotto, M., Saravia, F., & Beauquis, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.653651 · Cited by 117
Lipid metabolism reprogramming in renal cell carcinoma
Heravi, G., Yazdanpanah, O., Podgorski, I., Matherly, L. H., & Liu, W. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09996-w · Cited by 108
Li, X., Ge, J., Li, Y., Cai, Y., Zheng, Q., Huang, N., Gu, Y., Han, Q., Li, Y., Sun, R., et al. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.03.018 · Cited by 109
Johnson, S. M., Bao, H., McMahon, C. E., Chen, Y., Burr, S. D., Anderson, A. M., Madeyski-Bengtson, K., Lindén, D., Han, X., & Liu, J. (2024) · Nature Communications · doi:10.1038/s41467-024-49224-x · Cited by 100
First we eat, then we do everything else: The dynamic metabolic regulation of efferocytosis
Trzeciak, A. J., Wang, Y., & Perry, J. S. A. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.08.001 · Cited by 109
Cheng, H., Wang, M., Su, J., Li, Y., Jiao, L., Chu, J., Wan, X., Cao, Y., & Li, Q. (2022) · Life · doi:10.3390/life12060784 · Cited by 116
Cariello, M., Piccinin, E., & Moschetta, A. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.01.012 · Cited by 108
Cui, D., Yu, X., Guan, Q., Shen, Y., Liao, J., Liu, Y., & Su, Z. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00321-3 · Cited by 126
Parra-Landazury, N. M., Córdova‐Gallardo, J., & Méndez‐Sánchez, N. (2021) · Visceral Medicine · doi:10.1159/000515545 · Cited by 100
Lipid Metabolism in Oncology: Why It Matters, How to Research, and How to Treat
Matsushita, Y., Nakagawa, H., & Koike, K. (2021) · Cancers · doi:10.3390/cancers13030474 · Cited by 102
Cellular Responses to the Efferocytosis of Apoptotic Cells
Yin, C., & Heit, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.631714 · Cited by 101
Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions
Xu, G.-X., Song, W., Yu, C., Zhao, S., Yang, W., Feng, Y.-H., Pan, C., Kun-xing, Y., & Ma, Y. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1199519 · Cited by 93
The Fatty Acid Lipid Metabolism Nexus in COVID-19
Tanner, J. E., & Alfieri, C. (2021) · Viruses · doi:10.3390/v13010090 · Cited by 87
Emerging mechanisms and promising approaches in pancreatic cancer metabolism
Wu, H., Fu, M., Wu, M., Cao, Z., Zhang, Q., & Liu, Z. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06930-0 · Cited by 97
Wan, M., Pan, S., Shan, B., Diao, H., Jin, H., Wang, Z., Wang, W., Han, S., Liu, W., He, J., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02258-1 · Cited by 102
Dahik, V. D., Frisdal, É., & Goff, W. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155505 · Cited by 88
Research progress on post-translational modification of proteins and cardiovascular diseases
Cheng, X., Wang, K., Zhao, Y., & Wang, K. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01560-5 · Cited by 86
Striking a balance: new perspectives on homeostatic dendritic cell maturation
Bosteels, V., & Janssens, S. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01079-5 · Cited by 95
Wu, G., Wang, Q., Xu, Y., Li, J., Zhang, H., Qi, G., & Xia, Q. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1654-6 · Cited by 80
Liu, X., Sakai, H., Nishigori, M., Suyama, K., Nawaji, T., Shin, I., Nishigouchi, M., Okada, H., Matsushima, A., Nose, T., et al. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114610 · Cited by 78
Regulation of Brain Cholesterol: What Role Do Liver X Receptors Play in Neurodegenerative Diseases?
Mouzat, K., Chudinova, A., Polge, A. S., Kantar, J., Camu, W., Raoul, C., & Lumbroso, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163858 · Cited by 86
Endo‐Umeda, K., Kim, E., Thomas, D. G., Liu, W., Dou, H., Yalçınkaya, M., Abramowicz, S., Xiao, T., Antonson, P., Gustafsson, J.-Α., et al. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.317583 · Cited by 83
Cai, J., Zhang, M., Liu, Y., Li, H., Shang, L., Xu, T., Chen, Z., Wang, F., Qiao, T., & Li, K. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00500-5 · Cited by 78
Advancing targeted protein degradation for metabolic diseases therapy
Zhou, Q., Xiao, H., Yang, F., Wang, Y., Li, P., & Zheng, Z. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106627 · Cited by 77
Yin, J., Wang, J., Li, F., Yang, Z., Yang, X., Sun, W., Xia, B., Li, T., Song, W., & Guo, S. (2019) · Food & Function · doi:10.1039/c9fo00619b · Cited by 75
Wang, W., Wang, J., Zhang, H., Wu, S., & Qi, G. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00600 · Cited by 74
Miller, A. P., Coronel, J., & Amengual, J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158635 · Cited by 72
ABC Transporters, Cholesterol Efflux, and Implications for Cardiovascular Diseases
Wang, N., & Westerterp, M. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-6082-8_6 · Cited by 71
He, P., Gelissen, I. C., & Ammit, A. J. (2020) · Respiratory Research · doi:10.1186/s12931-020-01515-9 · Cited by 72
Gut microbiota modulation in Alzheimer's disease: Focus on lipid metabolism
Bonfili, L., Cuccioloni, M., Gong, C., Cecarini, V., Spina, M., Zheng, Y., Angeletti, M., & Eleuteri, A. M. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2022.01.025 · Cited by 69
Liu, X., Wu, J., Tian, R., Su, S., Deng, S., & Meng, X. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110433 · Cited by 68
Cholesterol metabolism: from lipidomics to immunology
Griffiths, W. J., & Wang, Y. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100165 · Cited by 68
The Promise of Niacin in Neurology
Wuerch, E. C., Urgoiti, G. B. R., & Yong, V. W. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01376-2 · Cited by 75
He, S., Xu, Z., & Han, X. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00803-6 · Cited by 62
Liver X Receptors Regulate Cholesterol Metabolism and Immunity in Hepatic Nonparenchymal Cells
Endo‐Umeda, K., & Makishima, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205045 · Cited by 68
Carpenter, K. J., Valfort, A.-C., Steinauer, N., Chatterjee, A., Abuirqeba, S., Majidi, S., Sengupta, M., DiPaolo, R. J., Shornick, L. P., Zhang, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-56038-1 · Cited by 67
Regulation and repurposing of nutrient sensing and autophagy in innate immunity
Sanchez‐Garrido, J., & Shenoy, A. R. (2020) · Autophagy · doi:10.1080/15548627.2020.1783119 · Cited by 67
Liu, M., Mu, J., Wang, M., Hu, C., Ji, J., Wen, C., & Zhang, D. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.131918 · Cited by 66
The genetic basis for adult onset glaucoma: Recent advances and future directions
Wang, Z., Wiggs, J. L., Aung, T., Khawaja, A. P., & Khor, C. C. (2022) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101066 · Cited by 64
Role of de novo cholesterol synthesis enzymes in cancer
Yang, J., Wang, L., & Jia, R. (2020) · Journal of Cancer · doi:10.7150/jca.38598 · Cited by 63
The Role of Lipid Metabolism in Gastric Cancer
Cui, M., Yi, X., Zhu, D., & Wu, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.916661 · Cited by 61
Aster-dependent nonvesicular transport facilitates dietary cholesterol uptake
Ferrari, A., Whang, E., Xiao, X., Kennelly, J. P., Romartinez-Alonso, B., Mack, J. J., Weston, T., Chen, K., Kim, Y., Tol, M. J., et al. (2023) · Science · doi:10.1126/science.adf0966 · Cited by 61
Self-citationDisrupted Lipid Metabolism in Multiple Sclerosis: A Role for Liver X Receptors?
Pineda‐Torra, I., Siddique, S., Waddington, K. E., Farrell, R. A., & Jury, E. C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.639757 · Cited by 63
Wang, M., Ma, H., Guan, S., Luo, T., Zhao, C., Cai, G., Zheng, Y., Jia, X., Di, J., Li, R., et al. (2021) · Food & Function · doi:10.1039/d1fo01495a · Cited by 63
Macrophage fatty acid oxidation inhibits atherosclerosis progression
Nomura, M., Liu, J., Yu, Z., Yamazaki, T., Yan, Y., Kawagishi, H., Rovira, I. I., Liu, C., Wolfgang, M. J., Mukouyama, Y., et al. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.01.003 · Cited by 61
Ménégaut, L., Thomas, C., Jalil, A., Julla, J., Magnani, C., Ceroi, A., Basmaciyan, L., Dumont, A., Goff, W. L., Mathew, M. J., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107665 · Cited by 60
Systems biology approaches to study lipidomes in health and disease
Alves, M. A., Lamichhane, S., Dickens, A. M., McGlinchey, A. J., Ribeiro, H. C., Sen, P., Wei, F., Hyötyläinen, T., & Orešič, M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158857 · Cited by 59
The Role of Nuclear Receptors in the Pathogenesis and Treatment of Non-alcoholic Fatty Liver Disease
Yang, Z., Danzeng, A., Liu, Q., Zeng, C., Xu, L., Mo, J., Ciren, P., Wang, X., Wang, C., Zhang, B., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.87305 · Cited by 61
Hyperuricemia induces lipid disturbances mediated by LPCAT3 upregulation in the liver
Liu, N., Sun, Q., Xu, H., Yu, X., Chen, W., Wei, H., Jiang, J., Xu, Y., & Lu, W. (2020) · The FASEB Journal · doi:10.1096/fj.202000950r · Cited by 57
Jiang, S., Yang, X., Yang, Z., Li, J., Xu, M., Qu, Y.-X., Tang, J., Li, Y., Wang, L., Shao, Y., et al. (2022) · Hepatology · doi:10.1002/hep.32381 · Cited by 58
The Multi-Level Regulation of Clownfish Metamorphosis Through Thyroid Hormones
Roux, N., Miura, S., Dussenne, M., Tara, Y., Lee, S., de Bernard, S., Reynaud, M., Salis, P., Barua, A., Boulahtouf, A., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2023.112661 · Cited by 57
Ni, M., Zhang, B., Zhao, J., Feng, Q., Peng, J., Hu, Y., & Zhao, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108778 · Cited by 58
Cao, Q. C., Liu, Z., Xiong, Y., Zhong, Z., & Ye, Q. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8893305 · Cited by 54
CRISPR screens for lipid regulators reveal a role for ER-bound SNX13 in lysosomal cholesterol export
Lu, A., Hsieh, F., Sharma, B. R., Vaughn, S. R., Enrich, C., & Pfeffer, S. R. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202105060 · Cited by 53
Central nervous system cholesterol metabolism in health and disease
Ho, W. Y., Hartmann, H., & Ling, S. (2022) · IUBMB Life · doi:10.1002/iub.2662 · Cited by 58
Ramón-Vázquez, A., de la Rosa, J. V., Tabraue, C., López, F., Díaz-Chico, B. N., Boscá, L., Tontonoz, P., Alemany, S., & Castrillo, A. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00376-18 · Cited by 58
Self-citationYang, X.-F., & Shang, D. (2023) · Cell Biology International · doi:10.1002/cbin.12065 · Cited by 54
Zhang, R., Shen, Y., Zhang, Q., Feng, X., Liu, X., Huo, X., Sun, J., & Hao, J. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06383-x · Cited by 53
Long noncoding RNA CHROMR regulates antiviral immunity in humans
Solingen, C. V., Cyr, Y., Scacalossi, K. R., de Vries, M., Barrett, T. J., de Jong, A., Gourvest, M., Zhang, T., Peled, D., Kher, R., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2210321119 · Cited by 52
Liver X receptor: a potential target in the treatment of atherosclerosis
Savla, S. R., Prabhavalkar, K. S., & Bhatt, L. K. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2117610 · Cited by 56
Fan, L., Jin, L., Tang, T., Zheng, Y., Chen, Z., Lin, H., Ding, C., Wang, T., Chen, H., Guo, Y., et al. (2023) · Theranostics · doi:10.7150/thno.90370 · Cited by 51
The Effects of Diosgenin on Hypolipidemia and Its Underlying Mechanism: A Review
Sun, F., Yang, X., Ma, C., Zhang, S., Yu, L., Lu, H., Yin, G., Liang, P., Feng, Y., & Zhang, F. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s326054 · Cited by 51
Guo, X. H., Zhong, J., Zhao, Y., Fu, Y., Sun, L., Yuan, A., Liu, J., Chen, A. F., & Pu, J. (2024) · Circulation · doi:10.1161/circulationaha.123.065202 · Cited by 51
PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer
Rademaker, G., Hernandez, G. A., Seo, Y., Dahal, S., Miller‐Phillips, L., Li, A. L., Peng, X. L., Luan, C., Qiu, L., Liegeois, M. A., et al. (2025) · Nature · doi:10.1038/s41586-025-09017-8 · Cited by 65
Self-citationTumor metabolic reprogramming in lung cancer progression (Review)
Li, X., Liu, M., Liu, H., & Chen, J. (2022) · Oncology Letters · doi:10.3892/ol.2022.13407 · Cited by 52
Screening for liver X receptor modulators: Where are we and for what use?
Buñay, J., Fouache, A., Trousson, A., de Joussineau, C., Bouchareb, E., Zhu, Z., Kocer, A., Morel, L., Baron, S., & Lobaccaro, J. A. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15286 · Cited by 54
SIRT6 controls hepatic lipogenesis by suppressing LXR, ChREBP, and SREBP1
Zhu, C., Huang, M., Kim, H.-G., Chowdhury, K., Gao, J., Liu, S., Wan, J., Li, W., & Dong, X. C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166249 · Cited by 50
LXR directly regulates glycosphingolipid synthesis and affects human CD4+ T cell function
Waddington, K. E., Robinson, G., Rubio-Cuesta, B., Chrifi-Alaoui, E., Andreone, S., Poon, K., Ivanova, I., Martin‐Gutierrez, L., Owen, D. M., Jury, E. C., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2017394118 · Cited by 55
PPAR-gamma agonists: Potential modulators of autophagy in obesity
Faghfouri, A. H., Khajebishak, Y., Payahoo, L., Faghfuri, E., & Alivand, M. R. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174562 · Cited by 51
Li, G., Li, X., Mahmud, I., Ysaguirre, J., Fekry, B., Wang, S., Wei, B., Eckel‐Mahan, K. L., Lorenzi, P. L., Lehner, R. S., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.163624 · Cited by 54
Fadel, L., Rehó, B., Volkó, J., Bojcsuk, D., Kolostyák, Z., Nagy, G., Müller, G., Simándi, Z., Hegedüs, É., Szabó, G., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011614 · Cited by 49
Landowski, M., & Rickman, C. B. (2021) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2021.0067 · Cited by 48
Yang, K., Zeng, C. C., Wang, C., Sun, M., Yin, D., & Sun, T. (2020) · Molecules · doi:10.3390/molecules25225439 · Cited by 49
Macrophage Efferocytosis in Cardiac Pathophysiology and Repair
Li, Y., Li, Q., & Fan, G. (2020) · Shock · doi:10.1097/shk.0000000000001625 · Cited by 47
Theoretical framework and emerging challenges of lipid metabolism in cancer
Gu, Q., Wang, Y., Yi, P., & Cheng, C. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.12.002 · Cited by 45
Vondra, S., Kunihs, V., Eberhart, T., Eigner, K., Bauer, R., Haslinger, P., Haider, S., Windsperger, K., Klambauer, G., Schütz, B., et al. (2019) · Journal of Lipid Research · doi:10.1194/jlr.p093427 · Cited by 46
Metadata
- Authors
- Wang, B., & Tontonoz, P.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Tontonoz, Peter
- Venue
- Nature Reviews Endocrinology
- Published
- 2018-06-14
- Volume
- 14
- Issue
- 8
- Pages
- 452-463
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- PMC
- PMC6433546
- OpenAlex
- W2808548053
- Cited by
- 722
- References
- 150
- Citations by year
- 2026: 89 · 2025: 111 · 2024: 110 · 2023: 117 · 2022: 81 · 2021: 94 · 2020: 64 · 2019: 48 · 2018: 8
- FWCI
- 11.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK114373)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Lipid Membrane Structure and Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- liver X receptor, liver X receptor alpha, LXRβ, nuclear receptors, cholesterol homeostasis, lipid metabolism, SREBP-1c, fatty acid metabolism, membrane homeostasis, polyunsaturated fatty acids, bile acid synthesis, lipoprotein production, intestinal stem cell proliferation, atherosclerosis, diabetes mellitus, cancer
- MeSH terms
- Liver X Receptors, Animals, Cholesterol, Gene Expression Regulation, Homeostasis, Humans, Signal Transduction, Needs Assessment, Lipid Metabolism, Translational Research, Biomedical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review